W. Thomas Mitchell

W. Thomas Mitchell discloses dealings in 2 companies, chiefly Neurocrine Biosciences Inc and DJ Orthopedics Inc. In total, 23 filings cover trades dated from 17 May 2006 to 23 June 2015.

Both buying and selling appear: 2 purchases worth €34k, against 9 sales worth €2.8M. Netting one side against the other leaves €2.8M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants and 9 option exercises. So far in 2015, the count stands at no purchases and 3 sales.

The latest filing, published on 24 June 2015, reports an option exercise of €89k in Neurocrine Biosciences Inc. The most recent open-market purchase was published on 6 November 2009, 6,196 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.